Accuracy of Whole-Blood Testing for Rapid Detection of Pregnancy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 633
- 试验地点
- 1
- 主要终点
- Detection of Pregnancy
研究概览
简要总结
It is common practice in the emergency medicine department to rapidly assess pregnancy status through the use of either urine or serum in pregnancy tests. Using whole blood instead of urine would facilitate a much more rapid emergency department identification of pregnancy status. No study to date has utilized whole blood for rapid detection of pregnancy status. Set in the busy adult emergency room at Maimonides Medical Center, this study will recruit a sample of women of reproductive age (18-55), who fit the inclusion criteria of being healthy and in need of a pregnancy test for own purpose or diagnostic testing/treatment. Blood samples will be taken from the participants and used in the hCG kits and the remaining blood was sent to the chemistry laboratory to perform the reference gold standard. The reference gold standard for a positive test is an hCG level >25mlU/ml. The research investigators and lab will be blinded to each other's results. Kappa statistics will be done for the measurement agreement between urine pregnancy results and whole blood pregnancy results, and whole blood results with laboratory results.
详细描述
Background and Significance:
Point-of-Care testing to rapidly detect pregnancy in women of reproductive age is common practice in Emergency Medicine departments. The patient history may not always reliably identify the possibility of pregnancy1, and a large proportion of these patients are exposed to potential teratogens because of their emergency department visit. In one study, 33% of such patients received a radiographic evaluation and 75% were prescribed a medication2. Additionally, a pregnancy test is required as the first step in the evaluation of a suspected, potentially life threatening, ectopic pregnancy3.
Commercially available rapid immunochemical assays detect human chorionic gonadotropin (hCG) concentrations >25 mlU/ml, and yield results at 3 minutes using urine and at 5 minutes using serum4-6. However, in clinical practice these tests may take much longer to perform due to significant delays in obtaining urine specimens from patients, or time delays required for separating serum from whole blood. By prolonging patient waiting time for further diagnostic testing and treatment, these delays may adversely impact on patient outcomes, emergency department crowding, and patient satisfaction.
Using whole blood for hCG immunoassay, instead of urine or serum, would facilitate much more rapid emergency department identification of pregnant patients. Whole blood can be obtained immediately during intravenous insertion of phlebotomy, or by finger stick puncture using a lancet in a manner similar to obtaining blood for bedside glucose determination.
Previous study of hCG immunoassays (which were less rapid than the immunoassays which are now commercially available and in use today) utilized whole blood as well as urine and serum, with equal sensitivities7. However, the accuracy of whole blood identifying pregnancy using presently available rapid immunochemical hCG test kits has not been validated.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 55 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy adult women of child bearing age.
- •Who either request a pregnancy test, or require a pregnancy test for diagnostic studies or treatment.
排除标准
- •Adults who are unable to independently give consent for study
- •Known pregnancy (i.e. - patient appears obviously pregnant)
- •Hemodynamically unstable.
- •Moderately to severely ill-appearing or in moderate to severe pain.
- •Technically not possible to obtain blood from the study subject.
结局指标
主要结局
Detection of Pregnancy
时间窗: Two years
Blood will be assessed in a pregnancy kit to assess the sensitivity and specificity of detecting whether or not the patient is pregnant. The laboratory results will be the gold standard.
次要结局
未报告次要终点
研究者
Antonios Likourezos
Research Manager
Maimonides Medical Center
